OverviewChartNewsTraderScreen

BVT Discount Zert AMD 28.03.2025/  DE000VG0FYB3  /

Frankfurt Zert./VONT
1/24/2025  1:48:21 PM Chg.-0.380 Bid3:30:33 PM Ask3:30:33 PM Underlying Strike price Expiration date Option type
101.660EUR -0.37% 101.760
Bid Size: 320		 101.800
Ask Size: 320		 Advanced Micro Devic... - USD 3/28/2025 Call
TeleTrader 12/23/2024 US chip firms' stock up on Biden's China probe
Newsfile Corp 12/10/2024 Railtown AI Accepted into the AMD Partner Network to Accelerate AI-driven Innovation
TeleTrader 11/18/2024 IBM unveils collaboration with AMD focused on AI
TeleTrader 11/13/2024 AMD cuts 4% of its global workforce
Newsfile Corp 10/30/2024 AI-powered Home Monitoring Data Presented at Academy 2024
TeleTrader 10/29/2024 AMD's Q3 revenue jumps 18% to $6.8B
TeleTrader 10/29/2024 Nasdaq surges 1% as tech sector leads gains
TeleTrader 10/29/2024 US open mostly lower ahead of major earnings
TeleTrader 10/29/2024 US mixed premarket ahead of big earnings
TeleTrader 10/17/2024 TSMC hits record high, surging 13% on profit growth
TeleTrader 10/15/2024 Nasdaq 100 drops by 1.3% on tech firms' losses
TeleTrader 10/10/2024 US stocks fall at close after latest CPI print
TeleTrader 10/10/2024 AMD unveils Ryzen AI PRO 300 Series processors for business PCs
TeleTrader 9/19/2024 Dow rises 650 pts, tops 42K for first time after Fed cut
TeleTrader 9/19/2024 Tesla shares up 5% amid broader tech rally after Fed rate cut
TeleTrader 9/11/2024 Oracle exec: AMD bearing well in Nvidia-dominated chip market
TeleTrader 9/6/2024 Dow loses 200 pts, Nasdaq slumps 2% on chips
GlobeNewswire 9/1/2024 Belite Bio Announces Appointment of Hendrik P. N. Scholl, MD, MA, as Chief Medical Officer
GlobeNewswire 8/30/2024 Opthea Reports Full-Year Financial Results and Business Updates
TeleTrader 8/28/2024 Dow down by 350 pts with tech sector in focus
GlobeNewswire 8/28/2024 PulseSight Therapeutics Confirms H2 2024 Conference Schedule
GlobeNewswire 8/27/2024 4DMT to Host 4D-150 Wet AMD Development Day on September 18, 2024
GlobeNewswire 8/27/2024 Clearside Biomedical Announces Completion of Final Participant Visit in ODYSSEY Phase 2b Trial of CL...
GlobeNewswire 8/27/2024 EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences
GlobeNewswire 8/26/2024 Aura Biosciences Announces the Presentation of Phase 2 End of Study Data Evaluating Suprachoroidal A...